The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization

por Zou, Jing, Xie, Xuping, Fontes-Garfias, Camila R., Swanson, Kena A., Kanevsky, Isis, Tompkins, Kristin, Cutler, Mark, Cooper, David, Dormitzer, Philip R., Shi, Pei-Yong
Publicado 2021

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

por Muik, Alexander, Wallisch, Ann-Kathrin, Sänger, Bianca, Swanson, Kena A., Mühl, Julia, Chen, Wei, Cai, Hui, Maurus, Daniel, Sarkar, Ritu, Türeci, Özlem, Dormitzer, Philip R., Şahin, Uğur
Publicado 2021

Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2

por Xia, Hongjie, Zou, Jing, Kurhade, Chaitanya, Cai, Hui, Yang, Qi, Cutler, Mark, Cooper, David, Muik, Alexander, Jansen, Kathrin U., Xie, Xuping, Swanson, Kena A., Shi, Pei-Yong
Publicado 2022

Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine

por Kurhade, Chaitanya, Zou, Jing, Xia, Hongjie, Cai, Hui, Yang, Qi, Cutler, Mark, Cooper, David, Muik, Alexander, Jansen, Kathrin U., Xie, Xuping, Swanson, Kena A., Shi, Pei‑Yong
Publicado 2022

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera

por Xie, Xuping, Zou, Jing, Fontes-Garfias, Camila R., Xia, Hongjie, Swanson, Kena A., Cutler, Mark, Cooper, David, Menachery, Vineet D., Weaver, Scott, Dormitzer, Philip R., Shi, Pei-Yong
Publicado 2021

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection

por Kurhade, Chaitanya, Zou, Jing, Xia, Hongjie, Liu, Mingru, Yang, Qi, Cutler, Mark, Cooper, David, Muik, Alexander, Sahin, Ugur, Jansen, Kathrin U., Ren, Ping, Xie, Xuping, Swanson, Kena A., Shi, Pei-Yong
Publicado 2022

A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults

por Baber, James, Arya, Mark, Moodley, Yuben, Jaques, Anna, Jiang, Qin, Swanson, Kena A, Cooper, David, Maddur, Mohan S, Loschko, Jakob, Gurtman, Alejandra, Jansen, Kathrin U, Gruber, William C, Dormitzer, Philip R, Schmoele-Thoma, Beate
Publicado 2022

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera

por Xie, Xuping, Liu, Yang, Liu, Jianying, Zhang, Xianwen, Zou, Jing, Fontes-Garfias, Camila R., Xia, Hongjie, Swanson, Kena A., Cutler, Mark, Cooper, David, Menachery, Vineet D., Weaver, Scott, Dormitzer, Philip R., Shi, Pei-Yong
Publicado 2021

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine

por Peterson, James T, Zareba, Agnieszka M, Fitz-Patrick, David, Essink, Brandon J, Scott, Daniel A, Swanson, Kena A, Chelani, Dhawal, Radley, David, Cooper, David, Jansen, Kathrin U, Dormitzer, Philip R, Gruber, William C, Gurtman, Alejandra
Publicado 2021

Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vac...

por Falsey, Ann R, Walsh, Edward E, Scott, Daniel A, Gurtman, Alejandra, Zareba, Agnieszka, Jansen, Kathrin U, Gruber, William C, Dormitzer, Philip R, Swanson, Kena A, Jiang, Qin, Gomme, Emily, Cooper, David, Schmoele-Thoma, Beate
Publicado 2021

BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants

por Liu, Jianying, Liu, Yang, Xia, Hongjie, Zou, Jing, Weaver, Scott C., Swanson, Kena A., Cai, Hui, Cutler, Mark, Cooper, David, Muik, Alexander, Jansen, Kathrin U., Sahin, Ugur, Xie, Xuping, Dormitzer, Philip R., Shi, Pei-Yong
Publicado 2022

A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine

por Walsh, Edward E, Falsey, Ann R, Scott, Daniel A, Gurtman, Alejandra, Zareba, Agnieszka M, Jansen, Kathrin U, Gruber, William C, Dormitzer, Philip R, Swanson, Kena A, Radley, David, Gomme, Emily, Cooper, David, Schmoele-Thoma, Beate
Publicado 2021

1941. Coadministration of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine With Influenza Vaccine in Older Adults

por Baber, James A, Quan, Karen, Athan, Eugene, Scott, Robert, Jaques, Anna, Jiang, Qin, Li, Wen, Cooper, David, Cutler, Mark W, Kalinina, Elena, Anderson, Annaliesa S, Swanson, Kena A, Gruber, William C, Gurtman, Alejandra C, Schmoele-Thoma, Beate
Publicado 2023

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults

por Murdoch, Louise, Quan, Karen, Baber, James A., Ho, Agnes W. Y., Zhang, Ying, Xu, Xia, Lu, Claire, Cooper, David, Koury, Kenneth, Lockhart, Stephen P., Anderson, Annaliesa S., Türeci, Özlem, Şahin, Uğur, Swanson, Kena A., Gruber, William C., Kitchin, Nicholas
Publicado 2023

91. Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization

por Simões, Eric A F, Madhi, Shabir A, Center, Kimberly J, Llapur, Conrado J, Novoa Pizarro, Jose M, Swanson, Kena A, Radley, David, McGrory, Stephanie B, Gomme, Emily A, Scott, Daniel A, Jansen, Kathrin U, Gruber, William C, Gurtman, Alejandra C
Publicado 2022

Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera

por Muik, Alexander, Lui, Bonny Gaby, Wallisch, Ann-Kathrin, Bacher, Maren, Mühl, Julia, Reinholz, Jonas, Ozhelvaci, Orkun, Beckmann, Nina, Güimil Garcia, Ramón de la Caridad, Poran, Asaf, Shpyro, Svetlana, Finlayson, Andrew, Cai, Hui, Yang, Qi, Swanson, Kena A., Türeci, Özlem, Şahin, Uğur
Publicado 2022

Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine

por Zou, Jing, Kurhade, Chaitanya, Patel, Sohil, Kitchin, Nicholas, Tompkins, Kristin, Cutler, Mark, Cooper, David, Yang, Qi, Cai, Hui, Muik, Alexander, Zhang, Ying, Lee, Dung-Yang, Şahin, Ugur, Anderson, Annaliesa S., Gruber, William C., Xie, Xuping, Swanson, Kena A., Shi, Pei-Yong
Publicado 2023

1632. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High Neutralizing Titers in Older Adults

por Fukushima, Yasushi, Cardona, Jose F, Zareba, Agnieszka, Jiang, Qin, Eiras, Daniel P, Patton, Michael, Ilangovan, Kumar, DeHaan, Elliot N, Mikati, Tarek, Kalinina, Elena, Cooper, David, Koury, Kenneth, Anderson, Annaliesa S, Swanson, Kena A, Gruber, William C, Gurtman, Alejandra C, Schmoele-Thoma, Beate
Publicado 2023

Neutralizing Activity of BNT162b2-Elicited Serum

por Liu, Yang, Liu, Jianying, Xia, Hongjie, Zhang, Xianwen, Fontes-Garfias, Camila R., Swanson, Kena A., Cai, Hui, Sarkar, Ritu, Chen, Wei, Cutler, Mark, Cooper, David, Weaver, Scott C., Muik, Alexander, Sahin, Ugur, Jansen, Kathrin U., Xie, Xuping, Dormitzer, Philip R., Shi, Pei-Yong
Publicado 2021

1630. Clinical Profile of Acute Respiratory Illness (ARI) Events in the Phase 3 Trial The RSV Vaccine Efficacy Study iN Older Adults Immunized against RSV Disease (RENOIR)

por Marc, Gonzalo Pérez, Walsh, Edward E, DeHaan, Elliot N, Llapur, Conrado J, Zareba, Agnieszka, Jiang, Qin, Ilangovan, Kumar, Woodside, John, Eiras, Daniel P, Mikati, Tarek, Kalinina, Elena, Cooper, David, Anderson, Annaliesa S, Swanson, Kena A, Gruber, William C, Gurtman, Alejandra C, Schmoele-Thoma, Beate
Publicado 2023